6505--Notice of Intent - Sole Source for Pluvicto

This opportunity is closed, click here to see similar open opportunities.

Title:  

6505--Notice of Intent - Sole Source for Pluvicto

Agency:  

U.S. Department Of Veterans Affairs

State:  

California

NAICS Code:  

325412

Industry:  

Healthcare and Medical Services

Solicitation Type:  

Sole Source

Solicitation ID:  

36C26125Q0797

Open Date:  

9/16/2025

Questions Due Date:  

9/17/2025

Close Date:  

9/19/2025

Project Duration:  

12 months

Last Updated:  

Description:
The Department of Veterans Affairs (VA) intends to award a sole source contract to Novartis Pharmaceuticals Corporation for the purchase of Pluvicto, a radiopharmaceutical used to treat prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer. The contract will be for a firm-fixed-price delivery order, with a period of performance from October 1, 2025, to September 30, 2026. The VA has determined that Novartis is the only source capable of providing the required supplies or services at the level of quality required, due to the highly specialized nature of the radiopharmaceutical. • The contract is for the purchase of Pluvicto, a radiopharmaceutical used to treat PSMA-positive metastatic castration-resistant prostate cancer. • The contract will be for a firm-fixed-price delivery order, with a period of performance from October 1, 2025, to September 30, 2026. • The VA has determined that Novartis is the only source capable of providing the required supplies or services at the level of quality required. • The contract is expected to be awarded on a sole source basis, with a value of approximately $4 million to $5 million.
Attached Files:

Please visit the bid source via the “Link to Bid Source” button below for documentation.

Contact Information:

Victoria Torres

victoria.torres@va.gov

Budget Estimate (AI):

$4,000,000 – $5,000,000

Based on the previous contract awards mentioned in the document, the estimated budget for this contract could be in the range of $4 million to $5 million. This is because the previous contracts awarded to Novartis and Advanced Accelerator Applications were for similar amounts, and the document mentions that the VA has already determined the prices of supplies under schedule contracts to be fair and reasonable. The budget could be influenced by factors such as the quantity of Pluvicto required, the duration of the contract, and the pricing schedule under the FSS contract.

Similar Opportunities powered by Bid Banana AI™

The Bid Lab’s Experts Are Ready To Help You Win RFPs

The Bid Lab is the only RFP consulting firm of its kind, specializing in guiding small and medium-sized businesses through the proposal response process. We have RFP experts ready to help you respond to that perfect opportunity you discover in Bid Banana.

  • Trusted by 100s of small business owners
  • Experience working on 1000s of RFP responses

  • Success stories in virtually every industry you can check out by clicking here.